findmyKOL

Toby Rogers, PhD

Enriched profile

Interventional Cardiologist and Scientific Lead, MedStar Heart & Vascular Institute Structural Heart Disease Program · MedStar Washington Hospital Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Washington, DC · Northeast · United StatesSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Toby Rogers is Interventional Cardiologist and Scientific Lead, MedStar Heart & Vascular Institute Structural Heart Disease Program at MedStar Washington Hospital Center. OpenAlex indexes 612 publications with 9,495 citations (h-index 48); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Toby Rogers is Interventional Cardiologist and Scientific Lead, MedStar Heart & Vascular Institute Structural Heart Disease Program at MedStar Washington Hospital Center (MedStar Heart & Vascular Institute). The public record shows 612 publications with 9,495 citations (h-index 48), centered on Cardiology. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 28 companies.

  • Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
  • Top research focus: Cardiology
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 28 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Prosthesis Failure1 trialHeart Failure1 trialCardiovascular Diseases1 trialVascular Diseases1 trialHeart Valve Diseases1 trialTricuspid Valve Insufficiency1 trial

Research focus

OpenAlex concept fingerprint
Cardiology

Drugs & molecules

across trials, industry payments and publications
Repathageneric · EvolocumabClinical trials—Industry payments19Publications—Brilintageneric · TicagrelorClinical trials—Industry payments11Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments9Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments8Publications—Kengrealgeneric · CangrelorClinical trials—Industry payments7Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments5Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments3Publications—Andexxageneric · Andexanet alfaClinical trials—Industry payments2Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments2Publications—NirmatrelvirClinical trials—Industry payments1Publications—RimegepantClinical trials—Industry payments1Publications—Xareltogeneric · RivaroxabanClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments349Edwards Lifesciences CorporationClinical trials—Industry payments219Boston Scientific CorporationClinical trials—Industry payments65Abbott LaboratoriesClinical trials—Industry payments20Amgen Inc.Clinical trials—Industry payments20AstraZeneca Pharmaceuticals LPClinical trials—Industry payments15Pfizer Inc.Clinical trials—Industry payments9Chiesi USA, Inc.Clinical trials—Industry payments7ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments7Novo Nordisk IncClinical trials—Industry payments6Ancora Heart, Inc.Clinical trials—Industry payments4Biotronik Inc.Clinical trials—Industry payments4AbiomedClinical trials—Industry payments3Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments3JenaValve Technology, Inc.Clinical trials—Industry payments3Teleflex LLCClinical trials—Industry payments3Cardiovascular Systems Inc.Clinical trials—Industry payments2E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Cardiva Medical, Inc.Clinical trials—Industry payments1Cook Medical LLCClinical trials—Industry payments1Cordis Us Corp.Clinical trials—Industry payments1Janssen Pharmaceuticals, IncClinical trials—Industry payments1Kestra Medical Technology Services, Inc.Clinical trials—Industry payments1Medstar Health Research InstituteClinical trials1Industry payments—P+F Products + Features USA Inc.Clinical trials1Industry payments—Recor Medical IncClinical trials—Industry payments1Shockwave Medical, IncClinical trials—Industry payments1W. L. Gore & Associates, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
612publications

Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.

9,495citations

Total citations across indexed works.

48h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
28companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    100%
    P2Y12 inhibitor100%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/toby-rogers-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Toby-Rogers-3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/MedStarResearch/status/1635756062463737856

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • PhD

    Department of Imaging Sciences and Biomedical Engineering, King's College London

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kclpure.kcl.ac.uk ↗
  • MA

    BM BCh, University of Oxford Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Editorial & leadership roles

journal and society appointments
  • Scientific Lead

    Structural Heart Disease Program, MedStar Heart & Vascular Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
  • Associate Editor (Imaging)

    JACC: Cardiovascular Interventions editorial board

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.